GRAS Notices
-
GRN No. 714
Subtilisin from Bacillus amyloliquefaciens produced in Bacillus subtilis
Intended Use: | For use in the processing of protein at 58-369 mg TOS/kg substrate to facilitate protein hydrolysis. |
---|---|
Basis: | Scientific procedures |
Notifier: | Danisco US Inc. (Dupont Industrial Biosciences) |
Notifier Address: |
925 Page Mill Road Palo Alto, CA, 94304 |
GRAS Notice (releasable information): | GRN 714 (in PDF) (10.8 MB) |
Date of closure: | Feb 6, 2018 |
FDA's Letter: | FDA has no questions (in PDF) (53 kB) |
-